Wealth Enhancement Advisory Services LLC Increases Position in Dolby Laboratories $DLB

Key Points

• Wealth Enhancement Advisory Services LLC increased its stake in Dolby Laboratories by 43.0% during the second quarter, owning a total of 17,356 shares valued at approximately $1.31 million.
• Analysts have set a consensus target price of $95.75 for Dolby Laboratories, with a "Moderate Buy" rating from multiple research firms.
• Insider trading activity includes CEO Kevin J. Yeaman selling 25,000 shares worth $1.79 million, indicating a reduction in their ownership by 17.89%.

Wealth Enhancement Advisory Services LLC increased its stake in Dolby Laboratories (NYSE:DLB - Free Report) by 43.0% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,356 shares of the electronics maker's stock after buying an additional 5,215 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Dolby Laboratories were worth $1,311,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in DLB. Alpine Bank Wealth Management purchased a new stake in shares of Dolby Laboratories in the first quarter worth $25,000. Cheviot Value Management LLC purchased a new stake in Dolby Laboratories during the 1st quarter valued at about $27,000. MAI Capital Management grew its position in Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock valued at $28,000 after purchasing an additional 162 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in Dolby Laboratories during the 1st quarter valued at about $29,000. Finally, Global X Japan Co. Ltd. purchased a new stake in Dolby Laboratories during the 1st quarter valued at about $51,000. Hedge funds and other institutional investors own 58.56% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Rosenblatt Securities reiterated a "buy" rating and set a $95.00 price target on shares of Dolby Laboratories in a report on Friday, August 1st. Barrington Research reiterated an "outperform" rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, September 12th. Tigress Financial increased their target price on Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a research note on Friday, August 15th. Baird R W raised Dolby Laboratories to a "hold" rating in a research report on Friday, September 5th. Finally, Robert W. Baird initiated coverage on Dolby Laboratories in a research report on Friday, September 5th. They set a "neutral" rating and a $74.00 price objective on the stock. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $95.75.

Insider Activity at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 25,000 shares of the business's stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $71.66, for a total value of $1,791,500.00. Following the transaction, the chief executive officer directly owned 114,725 shares of the company's stock, valued at approximately $8,221,193.50. The trade was a 17.89% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Shriram Revankar sold 7,000 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the transaction, the senior vice president owned 70,435 shares of the company's stock, valued at $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 99,366 shares of company stock worth $7,293,963 in the last three months. 38.39% of the stock is owned by corporate insiders.

Dolby Laboratories Price Performance

Shares of NYSE:DLB opened at $72.34 on Wednesday. The company has a market capitalization of $6.93 billion, a P/E ratio of 26.50 and a beta of 0.93. Dolby Laboratories has a 1-year low of $68.24 and a 1-year high of $89.66. The firm's 50 day simple moving average is $72.93 and its two-hundred day simple moving average is $74.68.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating the consensus estimate of $0.72 by $0.06. The firm had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company's revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm earned $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, sell-side analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were given a dividend of $0.33 per share. The ex-dividend date was Tuesday, August 12th. This represents a $1.32 annualized dividend and a dividend yield of 1.8%. Dolby Laboratories's dividend payout ratio (DPR) is currently 48.35%.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.